Insider · CIK 0001753134
Torben Lund-Hansen
Files at YMAB (Y-mAbs Therapeutics, Inc.). First filing Aug 30, 2024, latest Aug 30, 2024.
In brief
Torben Lund-Hansen files SEC Form 4 as officer at YMAB (Y-mAbs Therapeutics, Inc.). Since Aug 30, 2024, Torben Lund-Hansen has reported 0 open-market buys worth $0 and 1 open-market sell worth $769k, the latest filed on Aug 30, 2024.
A track record needs three past buys with six months of prices behind them; Torben Lund-Hansen has 0, so none is measured yet.
The newest scored trade: sold $769k of YMAB on Aug 28, 2024, filed Aug 30, 2024, scored 50 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Y-mAbs Therapeutics, Inc. | $769k 50,000 shares | -58% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 28, 2024 | YMAB Y-mAbs Therapeutics, Inc. | 50,000 0.11% of outstanding | $768k | Aug 28, 2024 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 28, 2024 | YMAB Y-mAbs Therapeutics, Inc. | MOption exercise Common Stock | +50,000 | $4.38 | $219k | 85,600 | Aug 30, 2024 |
| Aug 28, 2024 | YMAB Y-mAbs Therapeutics, Inc. | SOpen-market sale Common Stock | -50,000 | $15.37 | $769k | 35,600 | Aug 30, 2024 |
| Aug 28, 2024 | YMAB Y-mAbs Therapeutics, Inc. | MOption exercise Employee Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 100,000 | Aug 30, 2024 |
| Jan 18, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Common Stock | +17,800 | $0.00 | $0 | 35,600 | Jan 22, 2024 |
| Jan 18, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +35,700 | $0.00 | $0 | 35,700 | Jan 22, 2024 |
Questions about Torben Lund-Hansen
Answered from the filings on this page, as of the latest one.
Is Torben Lund-Hansen buying or selling?
Not in the last 12 months. Torben Lund-Hansen's latest open-market trade on SEC Form 4 was sold $769k of YMAB on Aug 28, 2024.
How did Torben Lund-Hansen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Torben Lund-Hansen has 0.
Where does Torben Lund-Hansen file Form 4?
Torben Lund-Hansen has filed Form 4 at YMAB (Y-mAbs Therapeutics, Inc.) as SVP & CHIEF TECHNICAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.